The study for the prevalence of HIV-associated neurocognitive disorder (HAND) in HIV-infected hemophilia

Not Applicable

• Conditions: Hemophilia, HIV infection

• Registration Number: JPRN-UMIN000021773
• Lead Sponsor: ational Center for Global Health and Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-05-01
• Study Completion: 2017-12-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Not provided

Exclusion Criteria

(1)Active AIDS-defining disease (2)Congenital developmental retardation (3)Definitive diagnosis of following diseases a. Mental disorder: major depressive disorder, schizophrenia b. Alzheimer's disease, Frontotemporallobar degeneration, Lewy-body disease, Vascular disease, Traumatic brain injury, Prion disease, Parkinson's disease, Huntington's disease c. Another functional neurocognitive disorder d. Illegal substance use e. Severe alcoholism f. Endocrine disorder : hypothyroidism, Wernicke encephalopathy, Vitamin B12 deficiency g. Current treatment or severe sequelae of CNS opportunistic infections h. Symptoms of a current, active infection a body temperature of >38.5 at the time of recruitment (4)Experience of neuropsychiatric test within past 1 year (5)Other inappropriate condition for neuropsychiatric test

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The prevalence of HIV-associated neurocognitive disorder in HIV-infected hemophilia